Olverembatinib

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)NCT06051409Ascentage Pharma Group Inc.Phase 3Recruiting2027-12-31Estimated
A Study of Olverembatinib in SDH-deficient GIST.NCT06640361Ascentage Pharma Group Inc.Phase 3Recruiting2027-03-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.